Insider Trading & Ownership - Hollander David

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Hollander David

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-07-01
Option Award
2024-07-03
3:15 pm
2025-07-01
2034-07-01
KIORA PHARMACEUTICALS INCKPRXHollander David
Director
1,778$01,778
(Direct)
View

Ownership
2024-02-29
4:32 pm
N/A
N/A
Revance Therapeutics Inc.RVNCHollander David
CMO & Global Therapeutics Lead
0$0278,522
(Direct)
View
2023-09-29
Option Award
2023-10-03
4:44 pm
N/A
2033-09-29
KIORA PHARMACEUTICALS INCKPRXHollander David
Director
0$05,000
(Direct)
View
2023-03-03
Option Award
2023-03-07
8:13 pm
N/A
2033-03-03
KIORA PHARMACEUTICALS INCKPRXHollander David
Director
8,000$08,000
(Direct)
View
2022-02-04
Tax Withholding
2022-02-08
8:40 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIHollander David
Chief R&D Officer
927$7.0530,749
(Direct)
View
2022-02-01
Option Award
2022-02-03
7:02 pm
N/A
2032-02-01
KIORA PHARMACEUTICALS INCKPRXHollander David
Director
9,000$09,000
(Direct)
View
2021-11-11
Tax Withholding
2021-11-15
4:44 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIHollander David
Chief R&D Officer
2,162$12.0631,676
(Direct)
View
2021-02-04
Option Award
2021-02-08
6:07 pm
N/A
2031-02-04
AERIE PHARMACEUTICALS INCAERIHollander David
Chief R&D Officer
61,000$083,838
(Direct)
View
2020-11-11
Tax Withholding
2020-11-12
5:05 pm
N/A
N/A
AERIE PHARMACEUTICALS INCAERIHollander David
Chief R&D Officer
2,162$13.0522,838
(Direct)
View
2019-11-11
Option Award
2019-11-13
4:08 pm
N/A
2029-11-11
AERIE PHARMACEUTICALS INCAERIHollander David
Chief R&D Officer
135,000$0135,000
(Direct)
View